Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
News
oembed
0
0
Related News
0
29 July, 2021
Medibiofarma announces first subject dosed in phase Ib multiple ascending dose study of MBF-118, a new PPARg covalent partial agonist, in healthy volunteers
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
No Comments
0
16 July, 2020
MEDIBIOFARMA ANNOUNCES FIRST SUBJECT DOSED IN MBF-118 CLINICAL STUDY: New PPARg covalent partial agonist in healthy volunteers
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
No Comments
0
13 February, 2019
Medibiofarma announces the nomination of a second Development Candidate
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
No Comments
0
3 September, 2026
Whales: Giants of the Ocean
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
No Comments
0
16 May, 2023
MEDIBIOFARMA announced the first patient dosed in the Phase IIa clinical trial of MBF-118 in patients with Crohn’s disease.
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
No Comments
0
9 September, 2025
Medibiofarma Receives 2nd Funding Award from the Crohn’s & Colitis Foundation to Support Development of a New Antifibrotic Therapy
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
No Comments
0
2 April, 2019
Medibiofarma announces the completion of a new financing round
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
No Comments
0
9 September, 2025
Medibiofarma Successfully Completes Phase 2A Clinical Trial of MBF-118 for Fibrotic Crohn’s Disease
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
No Comments
0
23 January, 2026
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
No Comments
0
11 March, 2025
Palobiofarma and Medibiofarma open new headquarters in the AINbuilding in Cordovilla, Spain
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health
No Comments